DE69822636D1 - Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe - Google Patents

Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe

Info

Publication number
DE69822636D1
DE69822636D1 DE69822636T DE69822636T DE69822636D1 DE 69822636 D1 DE69822636 D1 DE 69822636D1 DE 69822636 T DE69822636 T DE 69822636T DE 69822636 T DE69822636 T DE 69822636T DE 69822636 D1 DE69822636 D1 DE 69822636D1
Authority
DE
Germany
Prior art keywords
alopecia
sutism
seborrhoe
brain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69822636T
Other languages
English (en)
Other versions
DE69822636T2 (de
Inventor
Koichi Kojima
Takakazu Hamada
Shiroh Yosioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69822636D1 publication Critical patent/DE69822636D1/de
Publication of DE69822636T2 publication Critical patent/DE69822636T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69822636T 1997-07-29 1998-07-27 Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe Expired - Fee Related DE69822636T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29
JP20313697 1997-07-29
PCT/JP1998/003337 WO1999006050A1 (fr) 1997-07-29 1998-07-27 Agent reparateur contre la calvitie et autres maladies

Publications (2)

Publication Number Publication Date
DE69822636D1 true DE69822636D1 (de) 2004-04-29
DE69822636T2 DE69822636T2 (de) 2005-01-05

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69822636T Expired - Fee Related DE69822636T2 (de) 1997-07-29 1998-07-27 Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe

Country Status (22)

Country Link
US (1) US6380179B1 (de)
EP (1) EP0998930B1 (de)
KR (1) KR20010022066A (de)
CN (1) CN1129433C (de)
AT (1) ATE262337T1 (de)
AU (1) AU733830B2 (de)
BR (1) BR9811293A (de)
CA (1) CA2298851A1 (de)
DE (1) DE69822636T2 (de)
DK (1) DK0998930T3 (de)
ES (1) ES2218840T3 (de)
HK (1) HK1027290A1 (de)
HU (1) HUP0003159A3 (de)
ID (1) ID24566A (de)
IL (1) IL134199A0 (de)
NO (1) NO20000469L (de)
NZ (1) NZ502537A (de)
PL (1) PL338414A1 (de)
PT (1) PT998930E (de)
RU (1) RU2193887C2 (de)
TR (1) TR200000263T2 (de)
WO (1) WO1999006050A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20120245205A1 (en) 2009-07-29 2012-09-27 Delong Mitchell A Compositions and methods for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 ４−アザステロイド化合物
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
AU7078296A (en) 1995-09-27 1997-04-17 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
NZ326897A (en) * 1996-02-05 1999-08-30 Sankyo Co 5 <alpha>-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma

Also Published As

Publication number Publication date
WO1999006050A1 (fr) 1999-02-11
TR200000263T2 (tr) 2000-09-21
ID24566A (id) 2000-07-27
CN1129433C (zh) 2003-12-03
PT998930E (pt) 2004-05-31
CA2298851A1 (en) 1999-02-11
HUP0003159A3 (en) 2001-07-30
HUP0003159A2 (hu) 2001-04-28
IL134199A0 (en) 2001-04-30
BR9811293A (pt) 2000-08-29
NO20000469L (no) 2000-03-28
AU8358598A (en) 1999-02-22
ATE262337T1 (de) 2004-04-15
AU733830B2 (en) 2001-05-24
DE69822636T2 (de) 2005-01-05
DK0998930T3 (da) 2004-04-26
US6380179B1 (en) 2002-04-30
PL338414A1 (en) 2000-11-06
EP0998930A1 (de) 2000-05-10
NO20000469D0 (no) 2000-01-28
CN1271285A (zh) 2000-10-25
EP0998930A4 (de) 2002-06-12
ES2218840T3 (es) 2004-11-16
HK1027290A1 (en) 2001-01-12
KR20010022066A (ko) 2001-03-15
EP0998930B1 (de) 2004-03-24
NZ502537A (en) 2002-11-26
RU2193887C2 (ru) 2002-12-10

Similar Documents

Publication Publication Date Title
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
DE69822636D1 (de) Azasteroidverbindung zur behandlung von alopezie, hirsutismus und seborrhoe
DE69418744T2 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
DE69823650D1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
HUT71512A (en) N-(3-chlorophenyl)-piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE264840T1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
DE69902142T2 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE3770481D1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee